Darolutamide Oral Tablet

DRUG3 trials

Sponsors

Santa Chiara Hospital, Brazilian Clinical Research Institute, Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Conditions

Hormone Sensitive Prostate CancerMetastatic Hormone-Sensitive Prostate CanceMetastatic TumorProstate Cancer

Phase 2

Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer

Not yet recruitingNCT07717099

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARDMetastatic Hormone-Sensitive Prostate Cance

Start: 2026-09-01End: 2029-12-01Target: 50Updated: 2026-07-21

Phase 4

COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer

Active, not recruitingNCT06627530

Brazilian Clinical Research InstituteProstate Cancer

Start: 2025-02-17End: 2026-09-01Target: 144Updated: 2026-02-11

Unknown Phase

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

RecruitingNCT06473259

Santa Chiara HospitalHormone Sensitive Prostate Cancer, Metastatic Tumor, Prostate Cancer

Start: 2016-12-16End: 2028-12-31Target: 3000Updated: 2024-06-25